Shares of MedTech Delivery Firm Up on News of Pharma Acquisition

The early-stage medical technology company has presented some solid growth opportunities, and this company’s mission is to find and acquire these innovative companies.

Xcelerate, Inc. (OTCPK: XCRT) signed a Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC of Greenville, South Caroline, whereby Xcelerate will acquire 100% of the membership interests in HS Pharmaceuticals, LLC as well as a 51% interest in HS Cosmetics, Inc.

Xcelerate was designed to bridge the divide between initial non-medical engineering advancements and its application to clinical care. HS Pharmaceuticals is an early stage drug development company focusing on innovative immunotherapies for cancer treatment.

Shares were trading up over 9% in late-morning trade on the news, approaching their all-time high.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire